VEGFA and hypertensive disorder: As VSP inhibitors are increasingly used, additional studies are needed to better understand several aspects of HTN induced by VSP inhibition, such as the exact mechanisms by which VEGF signaling leads to vascular dysfunction, the optimal approach to blood pressure monitoring, and which antihypertensive agents and blood pressure targets could lead to improved outcomes.